Jeffrey A. Medin

7.6k total citations · 1 hit paper
181 papers, 5.8k citations indexed

About

Jeffrey A. Medin is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Jeffrey A. Medin has authored 181 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Molecular Biology, 65 papers in Genetics and 57 papers in Physiology. Recurrent topics in Jeffrey A. Medin's work include Virus-based gene therapy research (55 papers), Lysosomal Storage Disorders Research (49 papers) and CAR-T cell therapy research (31 papers). Jeffrey A. Medin is often cited by papers focused on Virus-based gene therapy research (55 papers), Lysosomal Storage Disorders Research (49 papers) and CAR-T cell therapy research (31 papers). Jeffrey A. Medin collaborates with scholars based in Canada, United States and France. Jeffrey A. Medin's co-authors include Walter Wahli, Keiko Ozato, Abderrahim Mahfoudi, C Dreyer, H. Keller, Thierry Levade, Daniel H. Fowler, Anton Neschadim, Takeya Sato and Roscoe O. Brady and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Jeffrey A. Medin

179 papers receiving 5.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers.

1993 808 citations Jeffrey A. Medin et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey A. Medin Canada	40	3.0k	1.2k	1.2k	1.2k	966	181	5.8k
Alan D. Friedman United States	46	4.4k 1.5×	1.0k 0.8×	638 0.5×	1.7k 1.5×	730 0.8×	128	7.0k
Luisa Lanfrancone Italy	38	4.9k 1.6×	1.6k 1.3×	894 0.7×	1.2k 1.0×	530 0.5×	95	7.8k
Robert P. Wersto United States	48	4.0k 1.3×	1.9k 1.5×	532 0.4×	1.4k 1.2×	841 0.9×	91	7.1k
Peter M. Finan United Kingdom	26	5.2k 1.7×	1.2k 0.9×	891 0.7×	1.4k 1.2×	417 0.4×	40	7.6k
Benjamin P.C. Chen United States	41	4.8k 1.6×	1.7k 1.3×	1.1k 0.9×	955 0.8×	396 0.4×	85	7.1k
Ivica Rubelj Croatia	15	3.8k 1.3×	1.1k 0.9×	3.5k 2.9×	872 0.7×	327 0.3×	37	6.8k
Sidney V. Suggs United States	19	2.3k 0.8×	1.1k 0.8×	773 0.6×	1.1k 0.9×	649 0.7×	24	5.5k
Gerardo Ferbeyre Canada	43	5.5k 1.8×	2.0k 1.6×	1.8k 1.5×	1.1k 0.9×	420 0.4×	122	7.8k
Masayoshi Namba Japan	35	2.8k 0.9×	1.1k 0.9×	630 0.5×	430 0.4×	594 0.6×	186	4.8k
Marta Cañamero Spain	43	5.6k 1.9×	2.6k 2.1×	1.6k 1.3×	951 0.8×	461 0.5×	67	8.4k

Countries citing papers authored by Jeffrey A. Medin

Since Specialization

Citations

This map shows the geographic impact of Jeffrey A. Medin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Medin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Medin more than expected).

Fields of papers citing papers by Jeffrey A. Medin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Medin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Medin. The network helps show where Jeffrey A. Medin may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Medin

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Medin. A scholar is included among the top collaborators of Jeffrey A. Medin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Medin. Jeffrey A. Medin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khan, Anzalee, Dwayne L. Barber, William M. McKillop, et al.. (2025). Lentivirus‐mediated gene therapy for Fabry disease: 5‐year End‐of‐Study results from the Canadian FACTs trial. Clinical and Translational Medicine. 15(1). e70073–e70073. 4 indexed citations

McKillop, William M., et al.. (2024). Cardiac dysfunction and altered gene expression in acid ceramidase-deficient mice. American Journal of Physiology-Heart and Circulatory Physiology. 328(1). H141–H156. 1 indexed citations

McKillop, William M., et al.. (2023). Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions. Biomolecules. 13(2). 274–274. 10 indexed citations

Kuchař, Ladislav, et al.. (2022). Skin inflammation and impaired adipogenesis in a mouse model of acid ceramidase deficiency. Journal of Inherited Metabolic Disease. 45(6). 1175–1190. 6 indexed citations

Liu, Haoyuan, et al.. (2022). rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis. Gene Therapy. 30(3-4). 297–308. 3 indexed citations

Li, Yedda, Yue Xu, Bruno A. Benítez, et al.. (2019). Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target. Proceedings of the National Academy of Sciences. 116(40). 20097–20103. 75 indexed citations

Sikora, Jakub, et al.. (2018). Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment. American Journal Of Pathology. 189(2). 320–338. 19 indexed citations

Sato, Takeya, Anton Neschadim, Ryo Nakagawa, Teruyuki Yanagisawa, & Jeffrey A. Medin. (2015). Evaluation of Bystander Cell Killing Effects in Suicide Gene Therapy of Cancer: Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis. Methods in molecular biology. 1317. 55–67. 2 indexed citations

Hirayama, S., Masaaki Sato, Séverine Loisel‐Meyer, et al.. (2013). Lentivirus IL-10 Gene Therapy Down-Regulates IL-17 and Attenuates Mouse Orthotopic Lung Allograft Rejection. American Journal of Transplantation. 13(6). 1586–1593. 38 indexed citations

10.

Wang, James C.M., et al.. (2013). Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways. Virology Journal. 10(1). 240–240. 8 indexed citations

11.

Williams, Brent A., Yoko Kosaka, Jeffrey A. Medin, et al.. (2012). Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model. Haematologica. 97(7). 1020–1028. 50 indexed citations

12.

Walia, Jagdeep S., Anton Neschadim, Xin Fan, et al.. (2011). Autologous Transplantation of Lentivector/Acid Ceramidase–Transduced Hematopoietic Cells in Nonhuman Primates. Human Gene Therapy. 22(6). 679–687. 26 indexed citations

13.

Felizardo, Tania C., Carole Evelegh, David Spaner, et al.. (2011). Differential immune responses mediated by adenovirus- and lentivirus-transduced DCs in a HER-2/neu overexpressing tumor model. Gene Therapy. 18(10). 986–995. 12 indexed citations

14.

Francia, Giulio, Shan Man, Christina R. Lee, et al.. (2009). Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2–Positive Human Breast Cancer Xenografts. Clinical Cancer Research. 15(20). 6358–6366. 33 indexed citations

15.

Medin, Jeffrey A., et al.. (2008). IL-10 Secretion Increases Signal Persistence of HEMA-MMA–Microencapsulated Luciferase-Modified CHO Fibroblasts in Mice. Tissue Engineering Part A. 15(1). 127–136. 10 indexed citations

16.

Underwood, James, et al.. (2008). Implementation of high-throughput screening for Fabry disease in Toronto dialysis patients. Clinical Kidney Journal. 1(2). 129–130. 7 indexed citations

17.

Francia, Giulio, Urban Emmenegger, Christina R. Lee, et al.. (2008). Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using β-human choriogonadotropin secreting tumor cell lines. Molecular Cancer Therapeutics. 7(10). 3452–3459. 21 indexed citations

18.

Bastianutto, Carlo, Asim Mian, Joseph D. Mocanu, et al.. (2007). Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow. Cancer Research. 67(21). 10112–10116. 29 indexed citations

19.

Neschadim, Anton, J. Andrea McCart, Armand Keating, & Jeffrey A. Medin. (2007). A Roadmap to Safe, Efficient, and Stable Lentivirus-Mediated Gene Therapy with Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 13(12). 1407–1416. 22 indexed citations

20.

Silvertown, Josh D., Jonathan Ng, Takeya Sato, Alastair J. S. Summerlee, & Jeffrey A. Medin. (2005). H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis. International Journal of Cancer. 118(1). 62–73. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact